Hepatocellular carcinoma1)
Hepatocellular carcinoma2)
1) Monotherapy study
2) Combination study
Cutaneous T-cell lymphoma (MF)
Squamous cell carcinoma
Basal cell carcinoma
Nucleotide DNA polymerase inhibitor (oral)
Nucleotide DNA polymerase inhibitor (oral)
Hepatocellular carcinoma1)
Phase I
Hepatocellular carcinoma2)
Phase II
Cathepsin K inhibitor
Cathepsin K inhibitor
Osteogenesis Imperfecta
Phase II
Osteoarthritis
Phase II
LCPD
Preclinical
1) Monotherapy study
2) Combination study
Hydrocortisone and aciclovir combination
Hydrocortisone and aciclovir combination
Labial herpes
Market
Partner: Vetbiolix
Cathepsin K inhibitor
Canine periodontitis
Phase II
Partner: Biossil Inc.
HDAC inhibitor (topical)
Cutaneous T-cell lymphoma (MF)
Phase II
Squamous cell carcinoma
Phase II
Basal cell carcinoma
Phase II